The FDA has signed off on the emergency use of Siemens Healthineers’ (OTCPK:SMMNY) lab-based blood test that detects the presence of IgG and IgM antibodies to the SARS-CoV-2 virus.
The company says the test, run on automated high-throughput instruments, sports 100% sensitivity and 99.8% specificity.
The company is a bit late to the COVID-19 blood test game, already crowded with competitors.
https://seekingalpha.com/news/3578980-fda-oks-emergency-use-of-siemens-covidminus-19-blood-test
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.